Ursula Seemüller

Title: The Innovative Contributions of Ursula Seemüller

Introduction

Ursula Seemüller is a notable inventor based in München, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. Her work has implications for pharmacology and therapeutic applications.

Latest Patents

Ursula Seemüller holds a patent for a "Process for preparing recombinant eglin, protease inhibitor." This invention involves DNA sequences that code for eglin, expression plasmids containing these sequences, and hosts transformed with such plasmids. The patent also covers novel eglin compounds produced from these transformed hosts, monoclonal antibodies against eglins, hybridoma cells that produce these antibodies, and test kits for immunoassays containing such antibodies. The eglins prepared through this process exhibit useful pharmacological properties.

Career Highlights

Ursula is associated with UCP Gen-Pharma AG, where she continues to advance her research and development efforts. Her work has positioned her as a key figure in her field, contributing to innovative solutions in biotechnology.

Collaborations

Ursula has collaborated with notable colleagues, including Hans Rink and Manfred Liersch. These partnerships have enhanced her research capabilities and broadened the impact of her inventions.

Conclusion

Ursula Seemüller's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence the development of therapeutic solutions.